Targeting the post-synaptic proteome has therapeutic potential for psychosis in Alzheimer DiseaseJosh M. Krivinko(University of Pittsburgh), Robert A. Sweet(University of Pittsburgh)Communications BiologyJune 2, 202310.1038/s42003-023-04961-5Cited by 7SaveCiteExport RISWatch citationsRelated PapersGenotype patterns at<i>PICALM, CR1, BIN1, CLU</i>, and<i>APOE</i>genes are associated with episodic memory|Neurology|2012|104Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease|Molecular Psychiatry|2021|68Differential regulation of <scp>MAP2</scp> by phosphorylation events in proline‐rich versus C‐terminal domains|The FASEB Journal|2023|6